AML is the second most common type of leukaemia, affecting around 3,100 people in the UK each year. It progresses rapidly, and current treatments, including chemotherapy and stem cell transplants ...

in combination with azacitidine and venetoclax for the treatment of older or unfit patients with newly diagnosed acute myeloid leukemia (AML). EVICTION is a first-in-human, dose-escalation (Part 1 ...

Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy with a poor prognosis for patients. Disulfidptosis response-related long non-coding RNAs (DRLs) have been demonstrated to be ...

The blood cancers acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) are extremely challenging to treat. While advances in immunotherapy have cured many patients with other blood cancers, ...

Part 2 comprises randomized dose-optimizing and efficacy estimating expansion cohorts of monotherapy (Group D: ovarian cancer; Group E: prostate cancer) and combination treatment of patients with AML ...

The move comes as India grapples with a rising burden of AML, particularly among its aging population. The company didn't disclose the pricing details of the drug. Currently, patients are ...